The new 6G phone technology that spots skin cancer sooner
Scientists have found a new way to detect any type of skin cancer in a matter of seconds. (Source: the Mail online | Health)
Source: the Mail online | Health - March 18, 2024 Category: Consumer Health News Source Type: news
New PD-1 Inhibitor Approved for Esophageal Cancer
(MedPage Today) -- The FDA approved tislelizumab (Tevimbra) for advanced/metastatic esophageal squamous cell carcinoma (ESCC) previously treated with chemotherapy, BeiGene announced.
The approval stipulates use of the PD-1 inhibitor in adults... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - March 15, 2024 Category: American Health Source Type: news
FDA Approves New Esophageal Cancer Drug FDA Approves New Esophageal Cancer Drug
The checkpoint inhibitor is approved for second-line treatment of patients with esophageal squamous cell carcinoma after prior systemic chemotherapy that did not include a PD-L1 inhibitor.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 15, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
FDA Approves Tevimbra (tislelizumab-jsgr) for the Treatment of Advanced or Metastatic Esophageal Squamous Cell Carcinoma
BASEL, Switzerland& BEIJING& CAMBRIDGE, Mass.--(BUSINESS WIRE)-- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has approved... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - March 14, 2024 Category: Drugs & Pharmacology Source Type: news
Florida Bill Addresses Coverage of Skin Cancer Screening Florida Bill Addresses Coverage of Skin Cancer Screening
Some 321,000 state employees would be eligible, at a cost of about $357,000 per year, according to one analysis.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 14, 2024 Category: Consumer Health News Tags: Dermatology Source Type: news
Beta-defensin index: A functional biomarker for oral cancer detection
Cell Reports Mediine AccessPublished:March 04, 2024DOI:https://doi.org/10.1016/j.xcrm.2024.101447SummaryThere is an unmet clinical need for a non-invasive and cost-effective test for oral squamous cell carcinoma (OSCC) that informs clinicians when a biopsy is warranted. Human beta-defensin 3 (hBD-3), an epithelial cell-derived anti-microbial peptide, is pro-tumorigenic and overexpressed in early-stage OSCC compared to hBD-2. We validate this expression dichotomy in carcinoma in situ and OSCC lesions using immunofluorescence microscopy and flow cytometry. The proportion of hBD-3/hBD-2 levels in non-invasivel...
Source: Dental Technology Blog - March 12, 2024 Category: Dentistry Source Type: news
Military Service Can Bring Melanoma Danger
TUESDAY, March 12, 2024 — U.S. military veterans, especially those who served in the Air Force, are at high risk for one of the deadliest skin cancers, melanoma.The risk owes to work hazards associated with service in countries near the equator... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 12, 2024 Category: General Medicine Source Type: news
Health device ethnic bias risking patients - study
The review focuses on devices frequently used in the NHS, like pulse oximeters and skin cancer apps. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - March 11, 2024 Category: Consumer Health News Source Type: news
Medical device bias needs urgent action - review
The review focuses on devices frequently used in the NHS, like pulse oximeters and skin cancer apps. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - March 11, 2024 Category: Consumer Health News Source Type: news
TIL for Melanoma: What Are the Costs and Challenges? TIL for Melanoma: What Are the Costs and Challenges?
A new FDA-approved treatment for melanoma has hit the market with a high price, and clinicians are working with insurers to determine out-of-pocket costs for patients.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 11, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
Does breast radiation therapy raise risk of skin cancer?
Radiation therapy for breast cancer treatment leads to an increased risk of skin cancer, according to research published March 8 in JAMA Network Open.
A team led by Shawheen Rezaei from Stanford University found that the risk of non-keratinocyte skin cancer diagnosis such as melanoma and hemangiosarcoma after breast cancer treatment with radiation was more than 50% higher.
“Although occurrences of non-keratinocyte skin cancers are rare, physicians should be aware of this elevated risk to help inform follow-up care,” the Rezaei team wrote.
While breast cancer treatment strategies have improved over the decades, survi...
Source: AuntMinnie.com Headlines - March 11, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: Subspecialties Womens Imaging Breast Breast Imaging Source Type: news
New NCCN Melanoma Guidelines Capture Evolving Best Practice New NCCN Melanoma Guidelines Capture Evolving Best Practice
NCCN guidelines for cutaneous melanoma, issued in February, capture evolving data for both diagnosis and treatment, diverging incrementally from 2019 AAD guidelines.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - March 9, 2024 Category: Internal Medicine Tags: Dermatology Source Type: news
Neoadjuvant Chemo Adds Significant Treatment Benefit in Penile Cancer
THURSDAY, March 7, 2024 -- Neoadjuvant chemotherapy (NAC) with lymphadenectomy for locally advanced penile squamous cell carcinoma (PSCC) is well tolerated and improves outcomes, according to a study published online Feb. 16 in the Journal of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 7, 2024 Category: Pharmaceuticals Source Type: news
The shocking photos that show the result of never wearing sunscreen or a hat - as skin cancer victim issues a warning to every Aussie
WARNING, GRAPHIC CONTENT: Leigh Raaschou, from Australia, spent countless hours working in the sun as a volunteer lifeguard but never wore a hat or sunscreen. (Source: the Mail online | Health)
Source: the Mail online | Health - March 7, 2024 Category: Consumer Health News Source Type: news
Ask Dr Rosemary Leonard: Why won't my GP monitor my skin cancer?
A reader wonders if their GP is right not to want to carry out further checks after a raised lump was found to be squamous cell cancer (Source: Daily Express - Health)
Source: Daily Express - Health - March 5, 2024 Category: Consumer Health News Source Type: news